Doctor profile · Federal record
Dr. FARRUKH ADHAMI, MD
Medical Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Hematology & Oncology Physician · FORT WAYNE, IN
- NPI 1598766925
- Accepts Medicare
- MIPS 82.2 / 100 · 2023
- 41 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2514 E DUPONT RD STE 100
FORT WAYNE, IN 468251619
(260) 484-8830
fax (260) 483-1911 - Mailing address
-
PO BOX 749495
ATLANTA, GA 303749495
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- May 15, 2025
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Indiana #01054856A
- Medicaid (2)
- OH #3044879 · IN #200349440
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1598766925. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
17,531
Distinct HCPCS
10
Medicare allowed
$150,776
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 13,770 | 15 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 988 | 42 | $0 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 582 | 273 | $118 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 460 | 22 | $1 | |
96375 |
Injection of additional new drug or substance into vein | 229 | 53 | $13 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 192 | 11 | $0 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 185 | 66 | $116 | |
96372 |
Injection of drug or substance under skin or into muscle | 151 | 35 | $13 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 126 | 74 | $163 | |
J3475 |
Injection, magnesium sulfate, per 500 mg | 122 | 13 | $1 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 977. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$3,988
Transactions
99
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $995.71 | |
| Janssen Biotech, Inc. | 11 | $573.55 | |
| Cornerstone Specialty Network LLC | 1 | $550.00 | |
| PFIZER INC. | 11 | $497.33 | |
| Merck Sharp & Dohme LLC | 15 | $276.59 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $189.59 | |
| Gilead Sciences, Inc. | 3 | $162.49 | |
| SOBI, INC | 6 | $124.90 | |
| BeiGene USA, Inc. | 1 | $117.58 | |
| Daiichi Sankyo Inc. | 4 | $80.78 | |
| Celgene Corporation | 4 | $64.03 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $59.23 | |
| Incyte Corporation | 3 | $51.86 | |
| ABBVIE INC. | 3 | $51.39 | |
| Karyopharm Therapeutics Inc. | 1 | $23.70 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
616
Patients
71
Total drug cost
$1,871,152
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Imbruvica (Ibrutinib) | Brand | 88 | 0 | $1,341,914 |
| Eliquis (Apixaban) | Brand | 83 | 19 | $68,146 |
| Anastrozole | Generic | 64 | 21 | $2,151 |
| Letrozole | Generic | 62 | 19 | $2,401 |
| Xarelto (Rivaroxaban) | Brand | 44 | 12 | $45,527 |
| Prednisone | Generic | 42 | 0 | $275 |
| Hydroxyurea | Generic | 41 | 0 | $1,356 |
| Abiraterone Acetate | Generic | 35 | 0 | $49,193 |
| Gabapentin | Generic | 33 | 0 | $967 |
| Potassium Chloride | Generic | 31 | 0 | $546 |